BVF Partners

Activity from announced rounds

All recorded activity
Rounds participated in
3
Confirmed lead rounds
0
1 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$527M
3 disclosed · full round size, not this investor’s share

By stage

Series B2
Undisclosed1

By primary sector

Biotech3

By country

United States3

Rounds

3 in all activity
Dren Bio

Dren Bio develops antibody therapies for cancer, autoimmune conditions and other serious diseases.

$350MPrivate financing
Participant
Ambrosia Biosciences

Drug-discovery company developing oral small-molecule treatments for obesity and metabolic disorders.

$100MSeries B
Participant